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Cycads, Flying Foxes, and Brain Disease in Humans
Logan Disney
Introduction
Cycads are seed plants with stout, woody trunks and a crown of large, stiff evergreen leaves
existing within tropical and subtropical regions of the world (Chamberlain, 1993). Cycads
dominated forest areas from around 250 million years ago to around 65 million years ago and are
among the most primitive of today’s seed plants; however, all extant cycads evolved within the
last 50 million years (Vessey, Pawlowski, & Bergman, 2004). All extant cycads belong to the
families Cycadaceae, Stangeriaceae, and Zamiaceae, and they participate in a symbiotic
relationship with nitrogen-fixing cyanobacteria (Thajuddin et al., 2010). These cyanobacteria
release compounds that, in addition to the cycad’s own toxins, can have neurotoxic effects if
consumed in sufficient doses. Though they have long been known to be toxic, cycad seeds are
eaten by humans after being washed and processed in an effort to remove the toxins. Cycad
seeds also make up a significant portion of the diet of some flying foxes. “Flying fox” is a
colloquial name referring to a bat of the genus Pteropus or the closely related Acerodon (De Jong
et al., 2013). They are a type of fruit-eating bat and are the largest bats in the world. They are
considered a delicacy in some regions and have been threatened by overhunting and
deforestation. Several species have gone extinct due to human activity. Flying foxes often share a
habitat with cycads, particularly in Old World tropical and subtropical regions such as the Pacific
Islands. Heavy consumption of cycad seeds leads to accumulation of toxic chemicals in the
tissues of flying foxes. Toxicity resulting from the consumption of cycads and flying foxes is
hypothesized to be a cause of significant neurological abnormality in humans including a severe
progressive neurodegenerative disease known as the amyotrophic lateral sclerosis and
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parkinsonism-dementia complex, or ALS-PDC (Spencer, Lasarev, Palmer, & Kisby, 2010). For
much of the twentieth century, incidence of ALS-PDC was far greater in tropical regions in
which cycads and flying foxes were common dietary items (Kurland & Mulder, 1954). For
example, the Chamorro people of Guam have traditionally consumed significant amounts of
cycads and flying foxes. The Chamorro also once had one of the highest known incidence rates
of ALS-PDC ever known, up to 200 cases per 100,000 people. The name of this disease reflects
the similarity of symptoms and neuropathology found in people suffering from ALS-PDC to that
of people afflicted with each of its namesake diseases—amyotrophic lateral sclerosis, abnormal
Parkinson’s disease, and dementia and Alzhiemer’s disease (Kuzuhara et al., 2001). Ethnic
groups in which ALS-PDC was once extraordinarily frequent have seen a sharp decline in
diagnoses upon reduction in their consumption of cycads and cycad-toxin-biomagnifying flying
foxes as they conform to modern life (Monson, Banack, & Cox, 2003).

Interspecies Relationships
There are numerous interspecies interactions that must be considered in order to fully understand
the relationships between cycads, flying foxes, and humans and the effects of these interactions
on the participants.

Cycads and Cyanobacteria
Cyanobacteria are unusual among prokaryotes in that they possess the capacity to perform
photosynthesis—in fact, the prevailing hypothesis on the origin of plant chloroplasts is an early
endosymbiotic event in which a cyanobacterium was taken up by a Eukaryotic cell (Raven &
Allen, 2003). Most cyanobacteria are also diazotrophic, which means they are able to fix
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atmospheric nitrogen (N2) into a usable form (Fay, 1992). Cyanobacteria are an important source
of fixed nitrogen in many ecosystems. They commonly fix nitrogen as free-living organisms or
within symbiotic relationships with a variety of fungi and plants (Vitousek et al., 2002). The only
known gymnosperms to participate in nitrogen fixation with cyanobacteria are cycads
(Thajuddin et al., 2010). It is thought that the relationship between cycads and cyanobacteria
began to develop during the time in which cycads dominated the world as early as 250 million
years ago.

Cycads associate with nitrogen-fixing cyanobacteria within specialized roots known as coralloid
roots that extend in branches above the ground or at shallow depths. The association of cycads
with cyanobacteria within specialized plant structures represent a truly mutualistic form of
nitrogen fixation (Vessey et al., 2004). This contrasts with the more common opportunistic type
of relationship in which free-living nitrogen-fixing bacteria release fixed nitrogen (usually in the
form of ammonia) into the environment, and this environmental nitrogen is subsequently taken
up by plants. The endophytic cyanobacteria that infect the coralloid roots of cycads are almost
entirely found within the genera Nostoc or Anabaena, though it is believed that the strains of
Anabaena participating in nitrogen-fixation symbiotic relationships with cycads would be redesignated as members of Nostoc if their taxonomy were to be re-evaluated with improved
criteria (Rippka, Deruells, Waterbury, Herdman, & Stanier, 1979). The cyanobacteria are
believed to enter the coralloid root through breaks in the root’s dermal layers within the soil
(Milindasuta, 1975). Several species of cyanobacteria can be found within a single cycad
(Lindblad, Haselkorn, Bergman, & Nierzwicki-Bauer, 1989). Cells within the endophyte cavity
of the coralloid root possess numerous outgrowths, abundant mitochondria, and many secretory
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granules outside the plasma membrane but within the cell wall. These structures grant the cycad
the ability to quickly and efficiently exchange nutrients with the nitrogen-fixing cyanobacteria,
reflecting the cycad’s adaptation to facilitate the symbiotic relationship. Within a single coralloid
root, a single species of cyanobacteria will outcompete all others, but different coralloid roots
within a single plant can host distinct species (Costa, Paulsrud, & Lindblad, 1999). Like other
diazotrophs, cyanobacteria possess a nitrogenase enzyme that ultimately converts atmospheric
nitrogen (N2) into ammonia (NH3) in a process that requires the cleavage of the triple bond
between the two nitrogen atoms in diatomic atmospheric nitrogen (C. Lee, Ribbe, & Hu, 2014).
This process requires energy input and is coupled to substantial input of ATP (16 molecules of
ATP are required for every molecule of N2 converted into 2 NH3) (C. Lee et al., 2014). The
relationship between cyanobacteria and cycads is mutualistic in that cyanobacteria obtain ATP to
carry out nitrogen fixation and other cellular processes, while cycads obtain a ready source of
usable nitrogen.

A consequence of the relationship between cycads and cyanobacteria is the accumulation in
cycad tissues of Β-methylamino-ʟ-alanine, or BMAA, a neurotoxic non-proteinogenic amino
acid secreted by many species of cyanobacteria. While cycads produce toxins of their own,
BMAA is the most well-researched of the cycad-involved toxins and has been suggested as a
possible cause of ALS-PDC.

Cycads and Flying Foxes
Flying foxes and cycads participate in a typical seed dispersal relationship. Bats are involved in
seed dispersal with many fruit-bearing organisms and have been shown to be quite effective seed
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dispersers (Medellin & Gaona, 1999). Animal seed dispersal in cycads is not a heavilyresearched topic, but bats were one of the first organisms described to disperse cycad seeds (Pijl,
1957). The bats are attracted to brightly colored seeds displayed by the cycad and consume the
fleshy, edible outer layer (sarcotesta) before discarding the remainder of the seed elsewhere, still
capable of germination. While the sarcotesta contains a relatively small quantity of BMAA,
consumption of many seeds and inadvertent consumption of other seed parts leads to the
accumulation of BMAA in flying fox tissues. This accumulation results in such biomagnification
of BMAA that consumption of a single flying fox by humans could give a dose of BMAA
comparable to consumption of 174 to 1,014 kilograms of processed cycad flour (Banack & Cox,
2003).

While cycads and flying foxes participate in a mutualistic interaction, it is unlikely that
substantial co-evolution has taken place because neither organism depends on the other. Cycad
seeds are only one of many sources of nutrients for flying foxes, and cycad seeds are often
dispersed by other animals including possums (Ballardie & Whelan, 1986).

Cycads and Humans
The fact that cycad seeds have been long known to contain toxins has not prevented humans
from finding ways to consume them. The Chamorro people of Guam traditionally made tortillas
and flour using ground cycad seeds. Other food items such as dumplings and thick soups were
also commonly produced from cycad seeds. The Chamorro were aware of the neurotoxic effects
of raw cycad seeds and developed methods to remove the toxins. Cycad seeds were washed in
water over the course of days or weeks with repeated changing of the wash water. BMAA and
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other toxins have been shown experimentally to dissociate from the seed as a result of these
water washes, although researchers have stated that the use of a less polar solvent such as ethanol
would be more effective (Spencer et al., 2010). The Chamorro believed the seeds were safe to eat
when “their chickens didn’t die after drinking the wash water (Holtcamp, 2012).” Rather than
risk losing chickens, some Chamorro stop washing the seeds when the “urine-like smell vanishes
(Banack, Murch, & Cox, 2006).” While BMAA has been shown to lead to neurodegeneration
and symptoms similar to ALS-PDC in animal models, the hypothesis that BMAA toxicity from
consumption of cycad seed-derived food products was briefly contested when it was reported
that the Chamorro washing procedure removed a sufficient amount of free BMAA to eliminate
the possibility of obtaining a toxic dose through eating seed-derived products (Duncan, Steele,
Kopin, & Markey, 1990). However, this conclusion was based on findings that most free BMAA
was successfully extracted by the washes. It was discovered in 2009 that a substantial amount of
additional BMAA exists in protein-bound form within cycad seeds, and this protein-bound
BMAA is not removed by Chamorro-like washing patterns; therefore, previous studies likely
underestimated the amount of BMAA consumed in cycad seed-derived food products (Cheng &
Banack, 2009). Therefore, BMAA toxicity through cycad seed consumption cannot be ruled out
as a possible cause of ALS-PDC.

Flying Foxes and Humans
Flying foxes are a traditional food item of several cultures within their territory. Flying fox meat
is considered a delicacy in Polynesia and Indonesia (Wheeler, 1979). The Chamorro people of
Guam, however, are more invested with flying fox consumption to the point at which “many
Chamorros believe that the consumption of flying foxes is central to their cultural identity
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(Banack et al., 2006).” The effect of human consumption of fruit bats on fruit bat populations
was significantly worsened in the twentieth century. Changes in trade and technology increased
the efficiency of flying fox hunting. Essentially, flying foxes were once considered an occasional
treat, hunted at a subsistence level using hand nets (Linsley, 1934). They began to be hunted with
firearms and traded for profit. In addition to increased popularity and hunting efficiency, other
human activity such as deforestation negatively impacted populations of flying fox. Due to
cultural pushback, flying foxes were not protected promptly and effectively until after the
extinction of some species and endangerment of others (Wheeler, 1979). An illegal flying fox
trade persisted for some time, and still exists to some degree, but is limited by a distinct lack of
flying foxes to hunt.

The Chamorro people of Guam prepare and eat flying foxes in their entirety. They are strewed
with water, vegetables, coconut milk, and MSG, and are then wholly consumed—meat, organs,
fur and all (Banack et al., 2006). They are commonly prepared for special occasions and served
along with cycad tortillas. Prior to the discovery that many studies had underestimated the
amount of BMAA present within washed cycad seeds (Cheng & Banack, 2009), the BMAA
hypothesis for ALS-PDC was contested due to the finding that a person could not obtain a
sufficient dose to produce symptoms by eating cycad seed-derived foods (Duncan et al., 1990).
The BMAA hypothesis was revitalized when it was discovered that flying foxes were shown to
contain considerable quantities of either free BMAA, protein-bound BMAA, or both forms of
BMAA in all body tissues (Banack et al., 2006). This was true in both raw flying fox tissues and
flying fox tissues that were subjected to traditional Chamorro preparation. Flying foxes serve to
biomagnify BMAA to such a degree that consumption of a single flying fox provides a
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substantially higher dose of BMAA than a person could obtain from directly eating food
prepared from cycad seeds (Banack et al., 2006). There are other commonly hunted local fauna
such as deer and feral pigs that consume cycad seeds and are also thought to cause BMAA
biomagnification, although they are not as well-studied as flying foxes.

Neuropathology
Patients suffering from the amyotrophic lateral sclerosis-parkinsonism dementia complex, or
ALS-PDC, present with symptoms and neuropathology that overlap those characteristic of ALS,
Parkinson’s Disease, and Alzheimer’s disease. Currently, a diagnosis of ALS-PDC cannot be
confirmed until after death (McGeer & Steele, 2011). The disease’s three distinct namesake
phenotypes tend to occur at different stages of life. It is uncommon for dementia to occur in
affected individuals until they have reached an advanced age, while ALS symptoms can develop
in adolescents or young adults. Parkinsonism most commonly appears during adulthood
(McGeer & Steele, 2011). It is noteworthy that, like many neurodegenerative diseases, ALSPDC can manifest quite differently from patient-to-patient. Some experience little to no dementia
and are capable of speech and rational thought even after they have become nearly paralyzed due
to the disease’s effects on motor neurons, while others express dementia-related behavioral and
emotional changes prior to significant loss of motor function (Steele, 2005).

ALS-PDC and Alzheimer’s Disease
A characteristic abnormality in the central nervous system shared by individuals with ALS-PDC
and those with Alzheimer’s disease is the presence of neurofibrillary tangles (NFTs) in both
neurons and glial cells due to aggregation of abnormal tau proteins. Properly functioning tau
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proteins serve to stabilize microtubules in neurons of the central nervous system. Tau proteins
are expressed at low levels in glial cells as well. In a disease known as a tauopathy, tau proteins
function abnormally. Many tauopathies involve the hyperphosphorylation of tau, which inhibits
tau binding and stabilization of microtubules and leads to the formation of large tau aggregates
known as NFTs (H. Lee et al., 2005). Misfolded tau proteins can induce the aggregation of other
tau proteins, so tauopathies are considered to progress in a prion-like manner (Krammer, Schätzl,
& Vorberg, 2001). Autopsies reveal that NFTs are found in the cortical areas of individuals who
were diagnosed with ALS-PDC to a much higher degree than those who were diagnosed with
only ALS. This leads to the conclusion that NFTs in cortical regions of the brain are involved in
the parkinsonism-dementia complex in ALS-PDC (Miklossy et al., 2005). Studies have also
found deposits of the Alzheimer’s disease hallmark β-amyloid deposits within the brains of ALSPDC-diagnosed individuals (Cox, Banack, & Murch, 2003). In a manner similar to that by which
misfolded tau leads to NFT, misfolded amyloid β proteins have a prion-like propagation leading
to oligomerization and formation of plaques. β-amyloid plaques are believed to be the most toxic
of the plaques that occur in Alzheimer’s disease (Zhao, Long, Mu, & Chew, 2012), so their
detection in ALS-PDC may contribute to the disease’s severity. Furthermore, individuals who
displayed more advanced symptoms of dementia showed reduced cortical thickness and
reduction in the volume of basal nuclei (Wilson et al., 2004). It should be noted that some ALSPDC patients do not develop Alzheimer’s disease-like symptoms. It is uncertain whether this is
more attributable to patients dying before reaching the late-in-life onset of dementia or a
different underlying etiology for the non-dementia cases. Mood swings and memory loss are
common signs of the dementia complex (Miklossy et al., 2005)
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ALS-PDC and Parkinson’s Disease
A pathological characteristic of ALS-PDC that is consistent with that of Parkinson’s disease is
mutation in α-synuclein (Yamazaki et al., 2000). α-synuclein is an abundant soluble protein in
the brain whose normal function is not known. Mutation of α-synuclein can lead to aggregation
and loss of solubility. Mutant α-synuclein is the primary component of a Lewy body—a mass of
insoluble protein aggregates that disrupt cellular function by displacing normal cell components
(Schulz-Schaeffer, 2010). Several diseases can result from mutation in α-synuclein mutation and
aggregation. These diseases are classified as synucleinopathies. It has been shown both in vitro
and in vivo that synucleinopathies and tauopathies can interact with one another, worsening
neurodegeneration in a “deleterious feed-forward loop (Moussaud et al., 2014).” ALS-PDC is an
example of a disease expressing both tauopathic and synucleophathic pathology, which may
contribute to the severity of the disease. In both ALS-PDC and Parkinson’s disease, Lewy body
buildup in neurons of the central nervous system is associated with the death of these neurons,
although the exact reason that Lewy body accumulation correlates with neuronal death is not yet
understood (Kalia & Lang, 2015). While the motor effects of both diseases are highly variable
from patient-to-patient, common symptoms include tremors, uncontrollable muscle tension, and
spasms. These motor symptoms are primarily the result of neuronal death within the substantia
nigra region of the midbrain (Dawson & Dawson, 2003).

ALS-PDC and ALS
The neuropathology and symptoms of ALS are almost entirely present in ALS-PDC. In both
diseases, substantial loss of motor neurons can be seen in the spinal cords of autopsied
individuals (Morris et al., 2001). A progressive decline in motor capabilities occurs in both
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diseases. A biological marker shared by ALS and ALS-PDC is TDP-43 aggregation (Miklossy et
al., 2005). Under normal conditions, TDP-43 is a DNA-binding protein that represses
transcription of HIV-1 and controls alternative splicing of other genes (Kuo, Doudeva, Wang,
Shen, & Yuan, 2009). In a diseased individual, TDP-43 is hyperphosphorylated and otherwise
modified to yield “pathogenic TDP-43” which forms toxic aggregations. Cycad consumption is
linked to the formation of TDP-43 aggregates through misincorporation of the non-proteinogenic
amino acid β-methylamino-ʟ-alanine, present in cycad seeds, during translation (Dunlop, Cox,
Banack, & Rodgers, 2013).

Etiology
The three most researched cycad toxins that have been named as potential causes for ALS-PDC
are: β-methylamino-ʟ-alanine, or BMAA; methylazoxymethanol, or MAM, which is derived
from cycasin; and β-sitosterol β-D-glucoside (BSSG). The most support in scientific literature
has been provided for BMAA, although there have been times in which BMAA was largely
rejected as a potential cause before being reinvigorated by new findings. While BMAA is
thought to have multiple modes of neurotoxicity, all three of these toxins share one
commonality: toxin-involved overstimulation of glutamate receptors leads to neuronal cell death.
The potential neurotoxic effects of the three toxins should not be viewed as alternative
hypotheses for the true one cause of ALS-PDC. It is possible that all these toxins, along with
other factors such as genetic predisposition and age of exposure, contribute to the etiology of the
disease and make individuals more susceptible to ALS-PDC.
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BMAA
β-methylamino-ʟ-alanine, or BMAA, is the most studied of the neurotoxins in cycad-related
neurodegeneration. Structurally, BMAA differs from the normal, proteogenic protein alanine
from which it is derived only by the addition of a methylamino group on the side chain. This
chemical substitution results in a distinct change in chemical properties—while the side chain of
alanine is small, nonpolar and hydrophobic, the side chain of BMAA has polar and basic
properties. As a common cyanobacterial neurotoxic secretion, BMAA is not limited to cycad
roots; it has been found in contaminated seafood and drinking water supplies as well (Holtcamp,
2012). BMAA is a non-proteinogenic amino acid, meaning it is not one of the twenty amino
acids that can be used by organisms to synthesize a polypeptide chain during protein synthesis.
Although DNA transcription and mRNA translation are highly controlled mechanisms with
specialized regulatory systems that help to prevent the addition of such abnormal amino acids to
a polypeptide sequence, BMAA and other incorrect amino acids may be included in a protein at
low error rates. For somatic cells, this is largely inconsequential because significantly affected
cells can undergo apoptosis and be replaced before the abnormal proteins can create large-scale
problems. However, neurons do not undergo such cellular replication. Abnormal proteins such as
those resulting from BMAA inclusion can accumulate in these cells. For this reason, neurons are
especially susceptible to the effects of BMAA toxicity. There are several neurotoxic effects that
have been linked to BMAA exposure, leading to the hypothesis that BMAA exposure from
cycad and flying fox consumption is to blame for the increased rate of ALS-PDC in the
Chamorro people of Guam and other populations.
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One mode of BMAA neurotoxicity involves improper inclusion of BMAA in polypeptide chains
leading to improper protein folding. This can result in the exposure of normally interior
hydrophobic amino acids, which are attracted to exposed hydrophobic amino acids in other
misfolded proteins. These intermolecular attractions between hydrophobic amino acids in
misfolded proteins result in the formation of small protein aggregates. Much like the propagation
of prion proteins in prion diseases, abnormal proteins containing BMAA can induce the
aggregation of other proteins. BMAA inclusion in polypeptides ultimately results in the
formation of large, toxic protein aggregates that may disrupt cellular function (Krammer et al.,
2001). The hypothesis that BMAA-induced misfolding was the cause of its neurotoxic effects
was criticized due to the high specificity of tRNA limiting the potential for a non-proteinogenic
amino acid such as BMAA to be incorporated into a polypeptide chain. However, it was later
discovered that BMAA can be mistaken for ʟ-serine by tRNA synthetase (Dunlop et al., 2013),
giving it the potential to be misincorporated into proteins at a higher rate than previously
thought. One specific protein that is particularly affected by BMAA misincorporation is TDP-43.
As previously discussed, TDP-43 aggregates are often found in post-mortem brain examinations
of people who died of amyotrophic lateral sclerosis (Igaz et al., 2011).

BMAA’s role in neurotoxicity is not limited to improper incorporation into polypeptide chains.
Direct exposure to unbound BMAA leads to substantial loss of motor neurons in spinal cord
culture due to overstimulation of glutamate receptors (Rao, Banack, Cox, & Weiss, 2006) .
Glutamate is an excitatory neurotransmitter whose overexpression can lead to toxic effects in
neurons. Glutamate-mediated excitotoxicity is characteristic of other neurodegenerative diseases
including Alzheimer’s disease (Hynd, Scott, & Dodd, 2004). BMAA-associated acute motor
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neuron loss was prevented in cultures including NBQX, a glutamate receptor antagonist. In
motor neurons, but not the remainder of spinal neurons, glutamate receptor overstimulation by
BMAA induced a toxic increase in production of reactive oxygen species. Extended BMAA
exposure depletes glutathione, an important antioxidant, which may worsen the effect of the
upregulated reactive oxygen species on cells (Rush, Lie, & Lobner, 2012). Glutamate receptor
overstimulation also leads to a substantial rise in intracellular calcium ion concentration (Rush et
al., 2012), which has been shown to correlate with neuronal degeneration (Hartley, Kurth,
Bjerkness, Weiss, & Choi, 1993). It is possible that the loss of spinal motor neurons resulting
from overstimulation of glutamate receptors by BMAA plays a role in the ALS-like
symptomology and pathology seen in most cases of ALS-PDC.

Cycasin & MAM
Unlike BMAA, cycasin is secreted by cycads themselves and not by a cyanobacterial endophyte.
Cycasin is an azoxyglucoside that is readily hydrolyzed through metabolism to form glucose and
methylazoxymethanol, or MAM. MAM is linked to carcinogenicity, hepatotoxicity, and
neurodegeneration in humans (Wilson, Khabazian, & Wong, 2002). One-time exposure to MAM
has been shown in animal models to lead to substantial DNA damage in the form of O6methyldeoxyguanosine lesions (Esclaire et al., 1999). As the name implies, these lesions involve
improper methylation of guanine nucleotides at the O6 position of the nitrogenous base. This
increases the likelihood of G:C-A:T mutations in DNA replication. It is believed that this occurs
when DNA polymerases mistake the O6-methylguanine as an adenine nucleotide due to the
conformational similarity of O6-methylguanine to adenine (Kisby et al., 2011).
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The link to O6-methylguanine-induced DNA replication errors readily explains the
carcinogenicity of MAM; if mutations continue to occur in certain signaling or replication
mechanisms, uncontrolled cell proliferation could result and lead to tumor formation. It is less
obvious how the DNA damage induced by MAM affects neurons of the central nervous system
that do not undergo mitosis. Convincing evidence toward the etiology of ALS-PDC resulting
from MAM toxicity was first presented in 2011, when unrepaired O6-methylation of neuronal
DNA in young animal models was linked to activation of signaling pathways associated with
neurodegeneration (Kisby et al., 2011). One such pathway involves upregulation of two distinct
glutamate receptors. As discussed in previous sections, glutamate-mediated excitotoxicity is
linked to neurodegeneration. These findings suggest that exposure to MAM through
consumption of cycad-derived foods in early life may contribute to the development of the
neurodegenerative ALS-PDC.

BSSG
Isolation of cycad seed compounds reveals that cycads contain numerous sterols (Marler &
Shaw, 2009). One of these sterols, β-sitosterol β-D-glucoside (BSSG), has been shown in
multiple animal models to have substantial neurotoxic effects (Wilson et al., 2002; Wilson,
2005). β-sitosterol (BSS) is a widely distributed sterol that was never considered as a candidate
for explaining cycad neurotoxicity due to its presence in many food items that are not linked to
neurodegenerative disease, such as vegetable oil and nuts (Anderson & Nabenhauer, 1924).
BSSG is a derivative of BSS that is rare in most organisms, but present in cycads. A 2002 study
revealed that, when neurodegeneration was triggered in animal models through cycad
consumption, the most toxic compound by some measures was BSSG; BMAA and MAM were
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only found to be present in trace amounts (Wilson et al., 2002). The neurotoxicity in this study
was quantified by measuring depolarizing field potentials leading to lactate dehydrogenase
release. Lactate dehydrogenase is a known marker for cell turnover and has been described
previously as useful for quantification of glutamate-mediated neuronal death (Koh & Choi,
1987). It is noteworthy that BSSG was found to be more toxic than BMAA and MAM by a
marker of neurotoxicity that is based upon glutamate-mediated neurotoxicity, considering that
this is a proposed mechanism of neurotoxicity for both of these compounds as well (as discussed
in previous sections). However, these studies took place prior to the finding that the methodology
of previous studies likely underestimated BMAA quantities in tissues.

Genetic Considerations
ALS-PDC was quickly ruled out as a genetic disorder. While most cases occurred in certain
populations, there are documented cases of people outside these populations contracting the
disease in the same geographic location. For example, a Caucasian man contracted ALS-PDC
after spending several years in Guam (Waring & Annegers, 1994). The fact that non-natives can
develop ALS-PDC in the same geographic location led to the conclusion that ALS-PDC is
primarily caused by environmental factors. However, while genetics are not the primary cause of
ALS-PDC, there are genetic factors that have been linked to increased or decreased susceptibility
to the disease.

Apolipoprotein E (ApoE) is a protein in mammals that is involved in fat and cholesterol
metabolism. It is produced by the liver for somatic tissues and produced by astrocytes for tissues
of the central nervous system (Liu, Kanekiyo, Xu, & Bu, 2013). The ApoE that is secreted by
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astrocytes is the primary carrier of cholesterol in the central nervous system (Puglielli, Tanzi, &
Kovacs, 2003). ApoE is heavily researched as a risk factor for Alzheimer’s disease (Liu et al.,
2013). In some populations, those who express the E4 variant of E4 carry 10 to 30 times the risk
for late-onset Alzheimer’s disease compared to the general population. In his 2005 dissertation,
Wilson (2005) published experiments on two considerations of the potential role of ApoE in
ALS-PDC. The first experiment sought to determine whether the presence or absence of ApoE
affected neurodegeneration in cycad-fed mice. He found that ApoE knockout mice did not show
the motor deficits that the ApoE wild type mice showed after being subjected to the same cycadrich diet. The second compared neurodegeneration in cycad-fed mice expressing different
isoforms of ApoE: human E2, E3, and E4 isoforms, as well as mouse wild-type ApoE. This
revealed that cycad-fed mice expressing human ApoE4 were particularly susceptible to motor
deficits, while those expressing E2 were somewhat protected (although still affected). The results
of these experiments indicate that ApoE plays some role in generating neurotoxicity from cycad
toxins, and humans expressing the E4 variant of ApoE may be more susceptible. The exact
mechanism is not known, although Wilson speculates that the cholesterol-carrying ApoE may
contribute to entry and metabolism of BSSG, a neurotoxic sterol found in cycad seeds and
discussed previously.

Another genetic factor that has been suggested to affect susceptibility to ALS-PDC is variation in
the microtubule associated protein tau gene, MAPT, which codes for the production of tau
proteins. Alternative splicing of MAPT results in the potential for multiple forms of tau to be
produced by the MAPT gene (Goedert, Wischik, Crowther, Walker, & Klug, 1988). MAPT
variation has been shown to increase susceptibility to other neurodegenerative diseases such as
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progressive supranuclear palsy (Conrad et al., 1999). A 2007 study comparing individuals
diagnosed with ALS-PDC to control groups identified two independent sites of genetic variation
within the MAPT gene that are associated with an increased risk of developing the disease
(Sundar et al., 2007).

Areas of Interest for Future Research
Findings based on molecular data revealed that all extant cycads evolved within the last 50
million years. Because all extant cycads possess coralloid roots to facilitate symbiosis with
cyanobacteria, it is possible that these structures helped these extant cycads to survive extinction
events, while any cycads that lacked coralloid roots died out. It is difficult to find literature on
the evolutionary origin of coralloid roots. If possible, future morphological and molecular studies
should be performed on cycad fossils to attempt to discover the point in cycad evolutionary
history at which coralloid roots are first seen.

More studies should be performed on biomagnification in mammals outside of flying foxes. If
cycad seed-eating feral pigs, deer, or possums accumulate BMAA or other toxins within their
tissues, consumption of these wild-caught animals should be avoided.

As the exact mechanisms of toxicity are elusive for all neurodegenerative diseases, further
studies should continue to seek to find the exact manner in which ALS-PDC and other diseases
progress. Markers such as NFT, β-amyloid plaques, Lewy bodies, and TDP-43 aggregations are
evidently associated, but it is not certain exactly how they cause toxicity or whether they are
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actually toxic or simply a by-product of unknown toxic mechanisms. Studies to identify other
genes that affect susceptibility to ALS-PDC should also be performed.

Conclusion
Cycads are ancient seed plants with a rich fossil history. Their association with nitrogen-fixing
cyanobacteria contributes to some, but not all, of their well-known toxicity. Flying foxes and
other cycad-fruit-eating mammals serve to biomagnify cycad toxins due to the accumulation of
these toxins within the mammals’ tissues. Consumption of cycad-derived foods and flying foxes
allows the effects of cycad toxins to manifest in humans and other animals. The interactions
between cycads, cyanobacteria, flying foxes, and humans may lead to a severe
neurodegenerative disease known as the amyotrophic lateral sclerosis and parkinsonismdementia complex, or ALS-PDC. Incidence of ALS-PDC has decreased accordingly with a
decrease in cycad and flying fox consumption among populations that previously expressed
extraordinarily high incidence rates of the disease.
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